An innovative framework to determine the implementation level of personalized medicine: A systematic review

Author:

Aguilera-Cobos Lorena,García-Sanz Patricia,Rosario-Lozano María Piedad,Claros M. Gonzalo,Blasco-Amaro Juan Antonio

Abstract

BackgroundPersonalized medicine (PM) is now the new frontier in patient care. The application of this new paradigm extends to various pathologies and different patient care phases, such as diagnosis and treatment. Translating biotechnological advances to clinical routine means adapting health services at all levels is necessary.PurposeThis article aims to identify the elements for devising a framework that will allow the level of PM implementation in the country under study to be quantitatively and qualitatively assessed and that can be used as a guideline for future implementation plans.MethodsA systematic review was conducted per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The research question was: What are the domains for determining the level of implementation of PM at the national level? The domains for assessing the degree of PM implementation, which would form the framework, were established.Results19 full-text studies that met the inclusion criteria were peer-selected in the systematic review. From all the studies that were included, 37 elements—encompassed in 11 domains—were extracted for determining the degree of PM implementation. These domains and their constituent elements comprise the qualitative and quantitative assessment framework presented herein. Each of the elements can be assessed individually. On the other hand, the domains were standardized to all have the same weight in an overall assessment.ConclusionsA framework has been developed that takes a multi-factorial approach to determine the degree of implementation of PM at the national level. This framework could also be used to rank countries and their implementation strategies according to the score they receive in the application of the latter. It could also be used as a guide for developing future national PM implementation strategies.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022338611, Identifier: CRD42022338611.

Funder

Ministerio de Sanidad, Consumo y Bienestar Social

Publisher

Frontiers Media SA

Subject

Public Health, Environmental and Occupational Health

Reference54 articles.

1. MadridISCIII.European Partnership for Personalised Medicine – EP PerMed2022

2. StrasbourgESFESF Forward Look. Personalised Medicine for the European Citizen2012

3. Personalized medicine in diabetes: the role of 'omics' and biomarkers;Pearson;Diabet Med.,2016

4. Nevado BlancoJ Arribas LópezJ Pérez JuradoLA Tenorio CastañoJA Martínez OlmosJ MadridFundación Instituto Roche.Medicina preventiva personalizada2018

5. Ciencias ómicas OrfaoA BenítezJ CorralesF Martín-SuberoI OrdovásJM CarracedoÁ MadridFundación Instituto Roche.2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3